Literature DB >> 32649218

Impact of Socioeconomic Position on Access to the U.S. Lung Transplant Waiting List in a Matched Cystic Fibrosis Cohort.

Carli J Lehr1, Aliza K Fink2, Melissa Skeans3, Albert Faro2, Gabriela Fernandez2, Elliott Dasenbrook1, Maryam Valapour1,3.   

Abstract

Rationale: Referrals for lung transplant and transplant rates in the United States are lower than in Canada for patients with advanced cystic fibrosis (CF) lung disease. Further study of factors limiting access are needed to optimize referral and transplant for this population.
Objectives: To determine the effect of socioeconomic position, while accounting for disease severity, on the likelihood of wait-listing for lung transplant in the United States.
Methods: A case-control study of 3,110 patients (1,555 wait-listed, 1,555 never wait-listed) in the linked CF Foundation Patient Registry/Scientific Registry of Transplant Recipients was performed with 1:1 matching for age, forced expiratory volume in 1 second, and year. Logistic regression was performed with univariate and multivariate analyses accounting for eight clinical factors (sex, oxygen use, body mass index, hemoptysis, forced vital capacity, methicillin-resistant Staphylococcus aureus, multidrug-resistant Pseudomonas aeruginosa, and i.v. antibiotic days) and six socioeconomic factors (race, marital status, education, health insurance, median zip code income, and distance to transplant program). The CF Health Score and Socioeconomic Barrier Score were created based on summation of variables. Interactions between scores were calculated.
Results: We found an inverse relationship between the probability of wait-listing and CF Health Score and Socioeconomic Barrier Score. As the CF Health Score decreased (less healthy), the probability of wait-listing increased by 69.3% from a score of 7 to 2. As the Socioeconomic Barrier Score decreased (fewer barriers), the probability of wait-listing increased by 31.7% from a score of ≥5 to 1). Regardless of illness severity, socioeconomic barriers presented an impediment to wait-listing. Individuals with higher Socioeconomic Barrier Scores accessed transplant about half as often as those with lower scores at the same level of medical severity. Analysis of interactions demonstrated a higher probability of wait-listing for individuals with moderate health severity and fewer social barriers compared with sicker individuals with more socioeconomic barriers.Conclusions: Accrual of socioeconomic barriers limits access to lung transplant irrespective of disease severity, a finding of substantial concern for patients with CF and for transplant providers. Future interventions can focus on this at-risk population early in the disease course.

Entities:  

Keywords:  cystic fibrosis; socioeconomic position; transplantation

Year:  2020        PMID: 32649218      PMCID: PMC7787007          DOI: 10.1513/AnnalsATS.202001-030OC

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN: 2325-6621


  33 in total

1.  Outcomes of adults with cystic fibrosis infected with antibiotic-resistant Pseudomonas aeruginosa.

Authors:  Noah Lechtzin; Majnu John; Rafael Irizarry; Christian Merlo; Gregory B Diette; Michael P Boyle
Journal:  Respiration       Date:  2005-08-17       Impact factor: 3.580

2.  Estrogen inhibition of cystic fibrosis transmembrane conductance regulator-mediated chloride secretion.

Authors:  A K Singh; B D Schultz; J A Katzenellenbogen; E M Price; R J Bridges; N A Bradbury
Journal:  J Pharmacol Exp Ther       Date:  2000-10       Impact factor: 4.030

3.  Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis.

Authors:  Kaïssa de Boer; Katherine L Vandemheen; Elizabeth Tullis; Steve Doucette; Dean Fergusson; Andreas Freitag; Nigel Paterson; Mary Jackson; M Diane Lougheed; Vijay Kumar; Shawn D Aaron
Journal:  Thorax       Date:  2011-06-15       Impact factor: 9.139

4.  Diabetes is associated with dramatically decreased survival in female but not male subjects with cystic fibrosis.

Authors:  Carlos E Milla; Joanne Billings; Antoinette Moran
Journal:  Diabetes Care       Date:  2005-09       Impact factor: 19.112

5.  Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis.

Authors:  G M Nixon; D S Armstrong; R Carzino; J B Carlin; A Olinsky; C F Robertson; K Grimwood
Journal:  J Pediatr       Date:  2001-05       Impact factor: 4.406

6.  The interplay of socioeconomic status, distance to center, and interdonor service area travel on kidney transplant access and outcomes.

Authors:  David A Axelrod; Nino Dzebisashvili; Mark A Schnitzler; Paolo R Salvalaggio; Dorry L Segev; Sommer E Gentry; Janet Tuttle-Newhall; Krista L Lentine
Journal:  Clin J Am Soc Nephrol       Date:  2010-08-26       Impact factor: 8.237

7.  Impact of burkholderia infection on lung transplantation in cystic fibrosis.

Authors:  Susan Murray; Jeffery Charbeneau; Bruce C Marshall; John J LiPuma
Journal:  Am J Respir Crit Care Med       Date:  2008-06-05       Impact factor: 21.405

8.  Body mass index as a predictor of survival in adults with cystic fibrosis referred for lung transplantation.

Authors:  G I Snell; K Bennetts; J Bartolo; B Levvey; A Griffiths; T Williams; M Rabinov
Journal:  J Heart Lung Transplant       Date:  1998-11       Impact factor: 10.247

9.  The Cystic Fibrosis Foundation Patient Registry. Design and Methods of a National Observational Disease Registry.

Authors:  Emily A Knapp; Aliza K Fink; Christopher H Goss; Ase Sewall; Josh Ostrenga; Christopher Dowd; Alexander Elbert; Kristofer M Petren; Bruce C Marshall
Journal:  Ann Am Thorac Soc       Date:  2016-07

10.  Survival Comparison of Patients With Cystic Fibrosis in Canada and the United States: A Population-Based Cohort Study.

Authors:  Anne L Stephenson; Jenna Sykes; Sanja Stanojevic; Bradley S Quon; Bruce C Marshall; Kristofer Petren; Josh Ostrenga; Aliza K Fink; Alexander Elbert; Christopher H Goss
Journal:  Ann Intern Med       Date:  2017-03-14       Impact factor: 25.391

View more
  5 in total

Review 1.  Socioeconomic determinants of respiratory health in patients with cystic fibrosis: implications for treatment strategies.

Authors:  Gabriela R Oates; Michael S Schechter
Journal:  Expert Rev Respir Med       Date:  2022-06-23       Impact factor: 4.300

2.  Survival and Lung Transplant Outcomes for Individuals With Advanced Cystic Fibrosis Lung Disease Living in the United States and Canada: An Analysis of National Registries.

Authors:  Kathleen J Ramos; Jenna Sykes; Sanja Stanojevic; Xiayi Ma; Joshua S Ostrenga; Aliza Fink; Bradley S Quon; Bruce C Marshall; Albert Faro; Kristofer Petren; Alexander Elbert; Christopher H Goss; Anne L Stephenson
Journal:  Chest       Date:  2021-04-17       Impact factor: 10.262

3.  Social Inequities and Cystic Fibrosis Outcomes: We Can Do Better.

Authors:  Gabriela R Oates; Michael S Schechter
Journal:  Ann Am Thorac Soc       Date:  2021-02

4.  Inequity and the Interstitium: Pushing Back on Disparities in Fibrosing Lung Disease in the United States and Canada.

Authors:  Adam W Gaffney; Anna J Podolanczuk
Journal:  Am J Respir Crit Care Med       Date:  2022-02-15       Impact factor: 30.528

5.  Disparities in Lung Transplant among Patients with Idiopathic Pulmonary Fibrosis: An Analysis of the IPF-PRO Registry.

Authors:  Aparna C Swaminathan; Anne S Hellkamp; Megan L Neely; Shaun Bender; Luca Paoletti; Eric S White; Scott M Palmer; Timothy P M Whelan; Daniel F Dilling
Journal:  Ann Am Thorac Soc       Date:  2022-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.